Background: To prevent cancer cervix, cervical cancer screening is one of the emerging health programme in all primary as well as tertiary care institution. In 2012, updated cervical cancer screening recommendation was released with consensus on Pappnicolaou ( PAP ) testing every 3 years for women aged 21 ? 65 years ( or ) PAP ? Humen Pailloma Virus ( HPV) co testing at 5 ? year intervals for women aged 30 ? 65 years. Materials and Methods: This prospective study was done at the tertiary care hospital from January 2017 to December 2017. 51 women were selected for screening HPV. The laboratory results were reported according to the new Bethesda system for reporting cervical cytology 2014. Results: Out of 51 cases, 17 HPV positive cases showed high risk genotype. Commonest high risk genotype detected was HPV 16 followed by HPV 35. And also 11 cases showed HPV positivity even with normal Pap smear study. Conclusion: HPV Testing along with pap smear are mandatory since there is high detection rate of HPV even in those with normal Pap smear.